Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA DR. REDDYS LAB CIPLA/
DR. REDDYS LAB
 
P/E (TTM) x 33.8 23.7 142.7% View Chart
P/BV x 4.3 3.8 113.0% View Chart
Dividend Yield % 0.5 0.7 65.6%  

Financials

 CIPLA   DR. REDDYS LAB
EQUITY SHARE DATA
    CIPLA
Mar-22
DR. REDDYS LAB
Mar-22
CIPLA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,0835,614 19.3%   
Low Rs8063,655 22.1%   
Sales per share (Unadj.) Rs269.71,294.6 20.8%  
Earnings per share (Unadj.) Rs31.7126.9 25.0%  
Cash flow per share (Unadj.) Rs44.8196.9 22.7%  
Dividends per share (Unadj.) Rs5.0030.00 16.7%  
Avg Dividend yield %0.50.6 81.8%  
Book value per share (Unadj.) Rs257.81,145.8 22.5%  
Shares outstanding (eoy) m806.81166.43 484.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.53.6 97.8%   
Avg P/E ratio x29.836.5 81.6%  
P/CF ratio (eoy) x21.123.5 89.7%  
Price / Book Value ratio x3.74.0 90.6%  
Dividend payout %15.823.6 66.7%   
Avg Mkt Cap Rs m762,177771,272 98.8%   
No. of employees `000NANA-   
Total wages/salary Rs m35,29938,858 90.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,633215,452 101.0%  
Other income Rs m3,2174,847 66.4%   
Total revenues Rs m220,851220,299 100.3%   
Gross profit Rs m43,29837,674 114.9%  
Depreciation Rs m10,52011,652 90.3%   
Interest Rs m1,064958 111.0%   
Profit before tax Rs m34,93329,911 116.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3388,789 106.2%   
Profit after tax Rs m25,59521,122 121.2%  
Gross profit margin %19.917.5 113.8%  
Effective tax rate %26.729.4 91.0%   
Net profit margin %11.89.8 120.0%  
BALANCE SHEET DATA
Current assets Rs m147,108177,880 82.7%   
Current liabilities Rs m49,12997,658 50.3%   
Net working cap to sales %45.037.2 120.9%  
Current ratio x3.01.8 164.4%  
Inventory Days Days6356 112.8%  
Debtors Days Days6113 5.1%  
Net fixed assets Rs m119,415106,819 111.8%   
Share capital Rs m1,614832 193.9%   
"Free" reserves Rs m206,364189,859 108.7%   
Net worth Rs m207,977190,691 109.1%   
Long term debt Rs m4,1625,746 72.4%   
Total assets Rs m266,523284,699 93.6%  
Interest coverage x33.832.2 105.0%   
Debt to equity ratio x00 66.4%  
Sales to assets ratio x0.80.8 107.9%   
Return on assets %10.07.8 129.0%  
Return on equity %12.311.1 111.1%  
Return on capital %17.015.7 108.0%  
Exports to sales %26.247.1 55.7%   
Imports to sales %8.218.8 43.6%   
Exports (fob) Rs m57,094101,544 56.2%   
Imports (cif) Rs m17,80340,401 44.1%   
Fx inflow Rs m60,180101,544 59.3%   
Fx outflow Rs m17,80340,401 44.1%   
Net fx Rs m42,37661,143 69.3%   
CASH FLOW
From Operations Rs m33,25928,108 118.3%  
From Investments Rs m-18,719-26,387 70.9%  
From Financial Activity Rs m-15,998-2,422 660.5%  
Net Cashflow Rs m-1,32332 -4,135.0%  

Share Holding

Indian Promoters % 13.5 26.7 50.5%  
Foreign collaborators % 20.1 0.0 -  
Indian inst/Mut Fund % 49.4 51.0 96.9%  
FIIs % 27.7 26.3 105.4%  
ADR/GDR % 0.0 10.1 -  
Free float % 66.4 63.2 105.0%  
Shareholders   388,864 259,271 150.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    SANOFI INDIA    


More on Cipla vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Dr. Reddys Share Price Performance

Period Cipla Dr. Reddys S&P BSE HEALTHCARE
1-Day 0.19% -0.16% -0.89%
1-Month -1.95% -4.08% -1.85%
1-Year 23.30% -4.72% -6.83%
3-Year CAGR 35.22% 14.40% 20.56%
5-Year CAGR 12.90% 14.79% 10.73%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

Dr. Reddys paid Rs 30.0, and its dividend payout ratio stood at 23.6%.

You may visit here to review the dividend history of Cipla, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

NTPC to Build Nuclear Fleet | Inox Group's Big Fundraise to Pare Debt | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets extended gains during the last hour of trade to end higher.